The prevalence of clotting disorders in a series of cases of thrombosis of the cerebral venous sinuses;Prevalencia de los trastornos de la coagulación en una serie de trombosis de senos venosos cerebrales

Revista de Neurologia

Volumn 45, Issue 11, 2007, Pages 661-664

  González Hernández, Ayoze ^a   Fabre Pi, O ^a   Lopez Fernandez J C ^a   Arana Toledo V ^a   Lopez Veloso C ^a   Suarez Munoz J ^a  

^a HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

Author keywords

Aetiology; Cerebral venous thrombosis; Coagulation; Prothrombotic; Thrombophilia; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR; PROTHROMBIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD CLOTTING DISORDER; CEREBRAL VENOUS SINUS THROMBOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MUTAGENESIS; PATHOPHYSIOLOGY; PREVALENCE; RETROSPECTIVE STUDY; THROMBOPHILIA; VEIN THROMBOSIS;

EID: 37349121827     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4511.2007096     Document Type: Article

References (32)

1. Bugnicourt JM, Roussel B, Tramier B, Lamy C, Godefroy O. Cerebral venous thrombosis and plasma concentrations of factor VIII and von Willebrand factor: a case-control study. J Neurol Neurosurg Psychiatry 2007; 78: 699-701.
2. Boncoraglio G, Carriero MR, Chiapparini L, Ciceri E, Ciusani E, Erbetta A, et al. Hyperhomocysteinemia and other thrombophilic risk factors in 26 patients with cerebral venous thrombosis. Eur J Neurol 2004; 11: 405-9.
3. Ventura P, Cobelli M, Marietta M, Panini R, Rosa MC, Salvioli G. Hyperhomocysteinemia and other newly recognized inherited coagulation disorders (factor V Leiden and prothrombin gene mutation) in patients with idiopathic cerebral vein thrombosis. Cerebrovasc Dis 2004; 17: 153-9.
4. Martinelli I, Battaglioli T, Pedotti P, Cattaneo M, Mannucci PM. Hyperhomocysteinemia in cerebral vein thrombosis. Blood 2003; 102: 1363-6.
5. Lüdeman P, Nabavi DG, Junker R, Wolf E, Papke K, Buchner H, et al. Factor V Leiden mutation is a risk factor for cerebral venous thrombosis. Stroke 1998; 29: 2507-10.
6. Deschiens MA, Conrad J, Horellou MH, Ameri A, Preter M, Chendru F, et al. Coagulation studies, factor V Leiden and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis. Stroke 1996; 27: 1724-30.
7. Hillier CE, Collins PW, Bowen DJ, Bowley S, Wiles CM. Inherited prothrombotic risk factors and cerebral venous thrombosis. QJM 1998; 91: 677-80.
8. Stolz E, Kemkes-Matthes B, Potzsch B, Hahn M, Kraus J, Wirbartz M. Screening for thrombophilic factors among 25 German patients with cerebral venous thrombosis. Acta Neurol Scand 2000; 102: 31-6.
9. Sánchez-Marín B, Grasa JM, Latorre A, Montañés MA, García-Erce JA, Torres M, et al. Hipercoagulabilidad hereditaria y adquirida en pacientes con trombosis venosa cerebral. Neurología 2002; 17: 405-9.
10. Ferro JM, Correia M, Pontes C, Baptista MV, Pita F, Cerebral Venous Thrombosis Portuguese Collaborative Study Group (Venoport). Cerebral vein and dural sinus thrombosis in Portugal: 1980-1998. Cerebrovasc Dis 2001; 11: 177-82.
11. Soria JM, Almasy L, Souto JC, Tirado I, Borell M, Mateo J, et al. Linkage analysis demonstrates that the prothrombin G20210A mutation jointly influences plasma prothrombin levels and risk of thrombosis. Blood 2000; 95: 2780-5.
12. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-703.
13. Biousse V, Conard J, Brouzes C, Horellou MH, Ameri A, Bousser MG. Frequency of the 20210 G→A mutation in the 3′-untranslated region of the prothrombin gene in 35 cases of cerebral venous thrombosis. Stroke 1998; 29: 1398-400.
14. Reuner KH, Ruf A, Grau A, Rickmann H, Stolz E, Juttler E, et al. Prothrombin gene G20210→A transition is a risk factor for cerebral venous thrombosis. Stroke 1998; 29: 1765-9.
15. Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med 1998; 338: 1793-7.
16. Van Krimpen J, Leebeek FW, Dippel DW, Gómez-García E. Prothrombin gene variant (G20210A) in a patient with cerebral venous sinus thrombosis. Clin Neurol Neurosurg 1999; 101: 53-5.
17. Sánchez-Marín B, Marta-Moreno E, Alarcia-Alejos R, López-Pérez A, Serrano-Ponz M, Latorre-Jiménez A. Trombosis venosa cerebral asociada a la variante G20210A del gen de la protrombina. Neurología 2000; 15: 473-84.
18. Castaman G, Tosetto A, Cappellari A, Ruggeri M, Rodeghiero F. The A20210 allele in the prothrombin gene enhances the risk of venous thrombosis in carriers of inherited protein S deficiency. Blood Coagul Fibrinolysis 2000; 11: 321-6.
19. Salomon O, Steinberg DM, Zivelin A, Gitel S, Dardik R, Rosenberg N, et al. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment. Arterioscler Thromb Vasc Biol 1999; 19: 511-8.
20. Uthman I, Khalil I, Sawaya R, Taher A. Lupus anticoagulant, factor V Leiden, and methylenetetrahydrofolate reductase gene mutation in a lupus patient with cerebral venous thrombosis. Clin Rheumatol 2004; 23: 362-3.
21. Mira Y, Alfaro A, Estelles A, Vaya A, Ferrando F, Villa P. Cerebral venous thrombosis associated to homozygous factor V Leiden mutation in a female of Syrian origin. Haematologica 2002; 87: ELT02.
22. De Bruijn SF, Stam J, Koopman MM, Vandenbroucke JP. Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users and in (correction of who are) carriers of hereditary prothrombotic conditions. The Cerebral Venous Sinus Thrombosis Study Group. BMJ 1998; 316: 589-92.
23. Dulli DA, Luzzio CC, Williams EC, Schutta HS. Cerebral venous thrombosis and activated protein C resistance. Stroke 1996; 27: 1731-3.
24. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, De Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
25. Faioni EM, Franchi F, Asti D, Mannucci PM. Activation of the protein C pathway in hereditary thrombophilia. Thromb Haemost 1998; 80: 557-60.
26. Halbmayer WM, Haushofer A, Angerer V, Finsterer J, Fischer M. APC resistance and factor V Leiden (FV:Q506) mutation in patients with ischemic cerebral events. Vienna Thrombophilia in Stroke Study Group (VITISS). Blood Coagul Fibrinolysis 1997; 8: 361-4.
27. Vieregge P, Schwieder G, Kompf D. Cerebral venous thrombosis in hereditary protein C deficiency. J Neurol Neurosurg Psychiatry 1989; 52: 135-7.
28. Kuwahara S, Abe T, Uga S, Mori K. Superior sagittal sinus and cerebral cortical venous thrombosis caused by congenital protein C deficiency: a case report. Neurol Med Chir (Tokyo) 2000; 40: 645-9.
29. Gokcil Z, Odabasi Z, Vural O, Yardim M. Cerebral venous thrombosis in pregnancy: the role of protein S deficiency. Acta Neurol Belg 1998; 98: 36-8.
30. Makris M, Leach M, Beauchamp NJ, Daly ME, Cooper PC, Hampton KK, et al. Genetic analysis, phenotypic diagnosis, and risk of venous thrombosis in families with inherited deficiencies of protein S. Blood 2000; 95: 1935-41.
31. Gerhardt A, Scharf RE, Zotz RB. Effect of hemostatic risk factors on the individual probability of thrombosis during pregnancy and the puerperium. Thromb Haemost 2003; 90: 77-85.
32. Derex L, Philippeau F, Nighoghossian N, Trouillas P, Berruyer M. Postpartum cerebral venous thrombosis, congenital protein C deficiency, and activated protein C resistance due to heterozygous factor V Leiden mutation. J Neurol Neurosurg Psychiatry 1998; 65: 801-2.